Updates in Therapeutic Strategies for Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach to Optimal Management of Adverse Effects, featuring Counseling Vignettes

This activity includes pharmacist-nurse-patient counseling vignettes

Program Description

Combination targeted therapies with immune checkpoint inhibitors (ICIs) and vascular endothelial growth factor (VEGF) inhibitors have demonstrated promising results as first-line therapy for metastatic renal cell carcinoma (RCC). Prognostic and patient-specific factors also guide therapy selection. With multiple combinations now approved for RCC, pharmacists and nurses must be familiar with their specific management considerations. Additionally, pharmacists and nurses should be familiar with overlapping toxicities of combination therapies and be able to educate patients on their occurrence and management. This activity will feature counseling scenarios showing communication among a pharmacist, nurse, and a patient with RCC about practical management strategies, administration of combination therapies, and mitigation of adverse effects. 

Target audience: Health-system pharmacists, oncology pharmacists, specialty pharmacists, nurses

Type of activity: Application
Release date: July 27, 2022
Expiration date: September 27, 2022

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Apply existing and emerging clinical research data to make evidence-based selection of treatment for advanced renal cell carcinoma (RCC)
• Determine when immunotherapy, targeted therapy, or combinations should be employed in the management of advanced RCC per guideline recommendations
• Examine the pharmacists’ and nurses’ roles in improving patient outcomes through coordination of care, management of toxicities, patient communication, education, and beyond

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-22-282-L01-P. The activity is available for CE credit through September 27, 2022.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

PER Accreditation Statement:

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 1.0 Contact Hours.

Disclosures

Megan Hinkley, PharmD, BCOP, has no relevant financial relationships with commercial interests to disclose.

The following contributors have no relevant financial relationships with commercial interests to disclose:

Medical Writer

Meg Taylor, PharmD, CPP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy Morris, PharmD; Abigail Dill; Susan Pordon; Brianna Winters; and Chloe Taccetta.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]

Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms